DaVita shares fell after the company's 2025 earnings missed expectations and Berkshire Hathaway sold shares in the company. The stock declined 10% to $158.96 on Friday, though it is up about 30% over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback